These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 2867163)

  • 1. Deviating central hypotensive activity of urapidil in the cat.
    van Zwieten PA; Mathy MJ; Thoolen MJ
    J Pharm Pharmacol; 1985 Nov; 37(11):810-1. PubMed ID: 2867163
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cardiovascular effects and interaction with adrenoceptors of urapidil.
    van Zwieten PA; de Jonge A; Wilffert B; Timmermans PB; Beckeringh JJ; Thoolen MJ
    Arch Int Pharmacodyn Ther; 1985 Aug; 276(2):180-201. PubMed ID: 4051641
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative effects of urapidil, prazosin, and clonidine on ligand binding to central nervous system receptors, arterial pressure, and heart rate in experimental animals.
    Kellar KJ; Quest JA; Spera AC; Buller A; Conforti A; Dias Souza J; Gillis RA
    Am J Med; 1984 Oct; 77(4A):87-95. PubMed ID: 6091452
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of urapidil on blood pressure and adrenoceptors in various animal models.
    van Zwieten PA; Mathy MJ; Thoolent MJ; Wilffert B; de Jonge A; Timmermans PB
    J Hypertens Suppl; 1984 Dec; 2(3):S539-41. PubMed ID: 6599713
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Involvement of brain 5-HT1A receptors in the hypotensive response to urapidil.
    Kolassa N; Beller KD; Sanders KH
    Am J Cardiol; 1989 Aug; 64(7):7D-10D. PubMed ID: 2569265
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacologic profile of urapidil.
    van Zwieten PA
    Am J Cardiol; 1989 Aug; 64(7):1D-6D. PubMed ID: 2569262
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Involvement of 5-HT1A receptors in blood pressure reduction by 8-OH-DPAT and urapidil in cats.
    Sanders KH; Beller KD; Kolassa N
    J Cardiovasc Pharmacol; 1990; 15 Suppl 7():S86-93. PubMed ID: 1702492
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacological activities of the antihypertensive drug urapidil in the rat.
    Verberne AJ; Rand MJ
    Clin Exp Pharmacol Physiol; 1984; 11(4):407-11. PubMed ID: 6097380
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacology of centrally acting hypotensive drugs.
    van Zwieten PA
    Br J Clin Pharmacol; 1980; 10 Suppl 1(Suppl 1):13S-20S. PubMed ID: 6104975
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interaction of urapidil with brain serotonin-1A receptors increases the blood pressure reduction due to peripheral alpha-adrenoceptor inhibition.
    Sanders KH; Beller KD; Bischler P; Kolassa N
    J Hypertens Suppl; 1988 Dec; 6(2):S65-8. PubMed ID: 2906703
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A benzodioxanhydroxyethylpiperidine derivative with an acute central hypotensive action, different from that of clonidine. A comparison with neuroleptic agents.
    Van Zwieten PA
    Arch Int Pharmacodyn Ther; 1975 May; 215(1):104-18. PubMed ID: 1156040
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of urapidil, clonidine, prazosin and propranolol on autonomic nerve activity, blood pressure and heart rate in anaesthetized rats and cats.
    Sanders KH; Jurna I
    Eur J Pharmacol; 1985 Apr; 110(2):181-90. PubMed ID: 3987812
    [TBL] [Abstract][Full Text] [Related]  

  • 13. On the mechanism of the hypotensive action of urapidil.
    Bousquet P; Feldman J; Schwartz J
    J Hypertens Suppl; 1985 Dec; 3(3):S187-9. PubMed ID: 2856701
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Experimental studies on the neurocardiovascular effects of urapidil.
    Gillis RA; Kellar KJ; Quest JA; Namath IJ; Martino-Barrows A; Hill K; Gatti PJ; Dretchen K
    Drugs; 1988; 35 Suppl 6():20-33. PubMed ID: 2900129
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of serotonin-1A receptor activation and alpha-1 adrenoceptor blockade in the hypotensive effect of 5-methyl-urapidil.
    Mandal AK; Kellar KJ; Gillis RA
    J Pharmacol Exp Ther; 1991 May; 257(2):861-9. PubMed ID: 1674536
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Central and peripheral hypotensive activity of urapidil and its M1 and M2 metabolites in the cat.
    Boss H; Boer R; Beller KD; Sanders KH
    Drugs; 1990; 40 Suppl 4():34-7. PubMed ID: 1982652
    [No Abstract]   [Full Text] [Related]  

  • 17. Importance of central nervous system serotonin-1A receptors for mediating the hypotensive effect of urapidil.
    Mandal AK; Kellar KJ; Friedman E; Pineo SV; Hamosh P; Gillis RA
    J Pharmacol Exp Ther; 1989 Nov; 251(2):563-70. PubMed ID: 2530339
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antihypertensive drugs interacting with alpha- and beta-adrenoceptors. A review of basic pharmacology.
    van Zwieten PA
    Drugs; 1988; 35 Suppl 6():6-19. PubMed ID: 2841084
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antagonism of hypotensive and bradycardic effects of centrally administered guanfacine by metiamide in anesthetized rabbits.
    Otorii T; Ohkubo K; Suzuki K
    Jpn Heart J; 1985 Jul; 26(4):577-84. PubMed ID: 2865383
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Central hypotensive and antihypertensive activities of imidazolidines, structurally related to clonidine.
    Timmermans PB; Van Zwieten PA
    Arch Int Pharmacodyn Ther; 1977 Aug; 228(2):251-67. PubMed ID: 921415
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.